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Vibrio cholerae O1 expresses a variety of cell surface factors which mediate bacterial adherence and coloni-
zation at the intestinal epithelium. The mannose-sensitive hemagglutinin (MSHA), a type IV pilus, is a
potential attachment factor of the V. cholerae El Tor biotype. We describe a TnphoA mutant that is defective in
its ability to hemagglutinate mouse erythrocytes. The TnphoA insertion maps to a recently identified genetic
locus that encodes products that are predicted to be essential for assembly and export of the MSHA pilus.
Insertional disruption at this locus in a mshA-phoA reporter strain provides evidence for a role of this locus in
the latter stages of pilus assembly and/or export. These constructs have provided physical markers by which
we have established close physical linkage of this secretion locus to a set of genes that includes the mshA
structural gene. Sequence analysis of the intervening region between these two loci has revealed the presence
of an open reading frame with homology to pilus biogenesis genes of several gram-negative bacteria. This
genetic organization suggests an entire operon encoding the MSHA pilus and the components necessary for its
assembly and secretion to the bacterial cell surface. The nomenclature of the MSHA structural and secretory
locus has been redefined accordingly.
Vibrio cholerae O1 is the etiologic agent of the acute diar-
rheal disease cholera. Pathogenic strains of V. cholerae O1 are
divided into two biotypes, classical and El Tor, on the basis of
a variety of phenotypic characteristics. Presently, the El Tor
biotype is of greatest social and scientific significance because
it is the prevalent biotype of the most recent pandemic. One
feature which distinguishes the El Tor from the classical bio-
type is the expression of a mannose-sensitive hemagglutinin
(MSHA) on the bacterial cell surface.
For V. cholerae to cause disease, the organism must attach to
the intestinal epithelium, where it can colonize and secrete its
potent exotoxin which is ultimately responsible for the massive
fluid efflux characteristic of cholera illness. The toxin-coregu-
lated pilus has been clearly established as a major determinant
of classical biotype colonization (11, 28). The role of the toxin
coregulated pilus in El Tor colonization has been controversial
(12, 19, 22, 26), and moreover, colonization is likely to be a
multifactorial process whereby several virulence determinants
act coordinately to establish favorable interactions at the in-
testinal epithelium (14). Therefore, recent investigations have
also focused on the role of MSHA in V. cholerae El Tor
pathogenesis.
The gene encoding the structural subunit of MSHA was
recently cloned and sequenced and found to reside within a
cluster of genes that encode type IV pilin-like proteins (13).
Recent work has demonstrated that proteins with extensive
sequence similarity to type IV pili are involved in extracellular
secretion and DNA uptake in a number of bacteria (25). It is
therefore possible that the MSHA gene locus is involved in a
number of bacterial functions, including attachment, coloniza-
tion, and extracellular secretion. A gene locus proposed to be
involved in MSHA secretion was also recently identified (10).
This locus consists of eight open reading frames (ORFs),
whose predicted gene products are homologs of several pro-
teins known to be involved in the extracellular secretion of
pullulanase by the bacterium Klebsiella oxytoca (21). Genetic
disruption in any one of six of the eight ORFs was shown to
abolish mannose-sensitive hemagglutination but did not inter-
fere with the secretion of other products such as cholera toxin
or extracellular protease (10).
In this study, we describe a TnphoA mutant that is defective
in its ability to hemagglutinate. The TnphoA insertion maps to
the fourth ORF of the MSHA secretory locus identified by
Hase et al. (10). This insertion plus several additional genetic
constructs was utilized to determine what role this ORF plays
in the generation of the MSHA phenotype. Additionally, the
TnphoA insertion was used as a physical marker to investigate
the location of the secretory genes with respect to the mshA
structural gene. The results of this analysis revealed that these
two sets of genes actually define a single locus. We propose
that this genetic arrangement defines the MSHA biogenesis
operon which is necessary for the expression, assembly, and
extracellular secretion of the MSHA pilus.
MATERIALS AND METHODS
Bacterial strains and plasmids. All V. cholerae strains described in this study
are derivatives of a spontaneous streptomycin-resistant mutant of a clinical
isolate of the El Tor strain C6706 (Table 1). The MSHA-negative mutant DS577
was obtained by screening a collection of C6706 TnphoA mutants for loss of the
ability to hemagglutinate mouse CD-1 erythrocytes. TnphoA mutagenesis was
performed with the pRT291 delivery vector as described previously (27).
Mutant strain JM34 was generated by genetic backcross of the cloned TnphoA
insertion from DS577 into wild-type C6706 by use of the IncP1 allelic exchange
method of Ruvkun and Ausubel (23). For this construction, Escherichia coli
SM10 (24) carrying plasmid pJM61 (Table 1) was mated with C6706 and then
selected on agar containing streptomycin and tetracycline. To select for chro-
mosomal recombinants that had lost plasmid pJM61 but had retained the inser-
tion due to homologous recombination into the chromosome, transconjugants
were mated with strain MM294 carrying the IncPI plasmid pPH1JI (23) and then
selected on agar containing streptomycin, kanamycin, and gentamicin.
The wild-type sequence corresponding to the region identified by the TnphoA
insertion was cloned by use of a linked marker strategy (20a). Initial sequence
* Corresponding author. Phone: (603) 650-1632. Fax: (603) 650-
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analysis was carried out with the United States Biochemical (Cleveland, Ohio)
Sequenase kit. This sequence was utilized to construct genetic disruptions of
ORF4 or ORF5 within the secretory locus by insertion of suicide vector pGP704
into the appropriate gene, similar to the procedure described by Miller and
Mekalanos (17). In this procedure, an internal fragment of either ORF4 or
ORF5 was inserted into pGP704, and the construct was recombined into the host
chromosome, resulting in two incomplete copies of the target gene. The internal
fragments were generated with PCR primers that flanked either an internal
220-bp fragment of ORF4 or an internal 170-bp fragment of ORF5. PCR primers
carrying appropriate restriction enzyme sites were synthesized with a Milligen/
Biosearch Cyclone Plus DNA synthesizer (model 8400; Perceptive Biosystems,
Framingham, Mass.). Primer sequences for the ORF4 construct are as follows:
59 sequence, 59-CTAGTCTAGAGTCACCTACAGTTATGCAGG-39; 39 se-
quence, 59-CTAGAATTTCGCCACTCTTTACCTGCCC-39. Primer sequences
for the ORF5 construct are as follows: 59 sequence, 59-CTAGTCTAGACATCG
TGATCCTGTTGAAGC-39; 39 sequence, 59-CTAGGAATTCGCCTTGGCTT
CGACATCTC-39. C6706 genomic DNA was utilized as template in a PCR
containing 0.2 mM each primer per construct. The resulting products were
digested with appropriate restriction enzymes and cloned into the multiple clon-
ing site of the suicide vector pGP704 which is ampicillin resistant. SM10lpir
carrying each plasmid construct was mated with C6706, and exconjugants were
selected on agar containing ampicillin and streptomycin. Homologous recombi-
nation by a single crossover event at either ORF4 or ORF5 in the V. cholerae
chromosome yields a duplication of the internal ORF sequences carried on the
plasmid, resulting in two incomplete, defective gene copies flanking the inserted
pGP704 DNA. Mutants JM2 and JM4 were isolated in this manner to carry
disruptions of ORF4 and ORF5, respectively.
A chromosomal mshA-phoA fusion was constructed in the following manner.
Two sets of PCR primers were designed to amplify flanking regions of the mshA
structural subunit gene. PCR products generated from these primers were cloned
in frame to the E. coli alkaline phosphatase gene from plasmid pPHO7 (9) and
then inserted into the pCVD442 (6) sucrase vector generating plasmid pJM62.
The PCR-generated flanking regions allow homologous recombination of the E.
coli alkaline phosphatase gene at the mshA gene locus in the V. cholerae chro-
mosome. The following primer set, designated primer set 1, amplified an
;350-bp fragment that overlaps the 39 end of mshB and the 59 end of mshA: 59
sequence, 59-AAAAGTCGACAGCGAAAGCGAATAGTGG-39; 39 sequence,
59-AAAAGGATCCATTGCACCAGCAACTGCACC-39. The following primer
set, designated primer set 2, amplified an ;250-bp fragment that overlaps the 39
end of mshA and the 59 end of mshC: 59 sequence, 59-AAAACTGCAGTCTA
GATCCTGCAACGGTTGCTATGC-39; 39 sequence, 59-AAAAGCATGCGT
GGTTACCACCGCAAAGG-39. Allelic exchange based on the sacB suicide
plasmid pCVD442 was utilized to replace the chromosomal mshA gene with the
alkaline phosphatase gene fusion in the following manner. SM10lpir carrying
pJM62 was mated with V. cholerae C6706. Progeny that had undergone genetic
recombination at the mshA locus was selected on agar containing ampicillin and
streptomycin as well as the chromogen XP (5-bromo-4-chloro-3-indoylphos-
phate). Blue, ampicillin-resistant exconjugants were plated on Luria-Bertani
(LB) agar with 6% sucrose and no salt (13) to select for progeny that had
undergone a second recombination event resulting in the loss of the pCVD442
vector sequences. A blue, sucrose-resistant colony that was ampicillin sensitive
was selected and designated strain JM53. This mshA-phoA strain was then sub-
jected to targeted gene disruption at ORF4 as described above, resulting in the
construction of strain JM73.
Hemagglutination assay. Hemagglutination assays were carried out in 96-well
round-bottom microtiter plates in a final volume of 0.2 ml. Bacteria (;107) were
serially diluted in Krebs-Ringer buffer (7). CD-1 mouse (Charles River Labora-
tories) erythrocytes were collected in the presence of heparin, washed three
times in Krebs-Ringer buffer, and resuspended at a final concentration of 1% in
Krebs-Ringer buffer. An equal volume of bacteria was mixed with the mouse
erythrocytes and incubated at room temperature for 1 h. Hemagglutination titers
are expressed as the reciprocal of the highest bacterial dilution that gave strong
hemagglutination (see Results).
Alkaline phosphatase assay. Alkaline phosphatase assays were performed on
mshA-phoA fusions, strains JM53 and JM73, as described previously (4). Briefly,
0.05 ml of bacteria from an overnight culture was lysed in 1 ml of 1 M Tris-HCl
(pH 8.0) containing 0.05 ml of 0.1% sodium dodecyl sulfate (SDS) and 0.05 ml
of chloroform and then incubated at 378C for 5 min. One-tenth milliliter of 0.4%
p-nitrophenyl phosphate was added to each sample, and incubation was contin-
ued at 378C until a yellow color appeared, at which time the reactions were
stopped by the addition of 0.1 ml of 1 M KH2PO4. Incubation times were noted,
and the optical densities at 420 and 550 nm (OD420 and OD550) of the reaction
mixture and the OD600 of the bacterial culture were read. Units of alkaline
phosphatase activity are expressed by the following formula:
alkaline phosphatase activity 5 1,000 3
OD420 2 (1.75 3 OD550)
time (min) 3 vol (ml) 3 OD600
Southern blot analysis. Verification of mutant constructs was performed by
Southern blot analysis. Two probes were amplified by PCR for Southern blot
analysis. Probe A (Fig. 1A), which spans ORF4 and the 59 end of ORF5, was
generated with the 59 primer from the ORF4 genetic disruption protocol and
the 39 primer 59-CTAGGAATTCGCCTTGGCTTCGACATCCTC-39. Probe B
(Fig. 1A), which spans the entire mshA coding region, was generated with the
distal primers for the mshA-phoA gene fusion construction. The resultant prod-
ucts were random prime labeled with digoxigenin dUTP by use of the Boehringer
Mannheim (Indianapolis, Ind.) Genius System Kit. Genomic DNA was isolated
by phenol extraction (16) and digested with SmaI (unless otherwise noted) at
258C for 3 h. DNA digests were run on 0.7% agarose gels and immobilized on
Illuminator nylon membrane (Stratagene, La Jolla, Calif.) by capillary action and
UV cross-linkage (Stratalinker; Stratagene). Hybridization was performed at
428C overnight; high-stringency washes in 0.53 SSC (13 SSC is 0.15 MNaCl plus
0.015 M sodium citrate)–0.1% SDS at 658C followed. Detection was carried out
with alkaline phosphatase-conjugated antidigoxigenin antibodies and Lumiphos
substrate (Boehringer Mannheim), followed by overnight exposure of XAR film
(Eastman Kodak Co., Rochester, N.Y.).
Automated sequencing of intervening sequence. The PCR primers MSH6 and
MSH7 were designed to flank the intervening region between mshE of the
TABLE 1. Bacterial strains and plasmids
Strain or plasmid Descriptiona Source or reference
Strains
E. coli
SM10 thi thr leu tonA lacY supE recA [RP4-2-Tc::Mu] 24
SM10lpir SM10lpirR6K 27
MM294 endA hsdR pro supF 23
V. choleraeb
C6706 Smr; wild-type El Tor, Inaba Lab collection
DS577 Kmr; TnphoA mutant; MSHA negative This study
JM34 Kmr; TnphoA backcross mutant This study
JM2 Apr; pGP704 disruption mutant of ORF4 This study
JM4 Apr; pGP704 disruption mutant of ORF5 This study
JM53 mshA-phoA alkaline phosphatase gene fusion This study
JM73 Apr; pGP704 disruption mutant of ORF4 in JM53 This study
Plasmids
pJM61 Tcr Kmr; pLAFR2 derivative containing 20-kb DS577 TnphoA XbaI fragment This study
pLAFR2 IncP1 Tcr 8
pPHO7 Apr9 phoA 9
pPH1JI Gmr Smr tra IncP1 23
pGP704 Apr, suicide vector, oriR6K mobRP4 17
pCVD442 Apr sacB, pGP704 derivative 6
pJM62 pCVD442::mshA-phoA This study
a Abbreviations: Tcr, tetracycline resistance; Kmr, kanamycin resistance; Apr, ampicillin resistance; Smr, streptomycin resistance; Gmr, gentamicin resistance.
b All V. cholerae strains are derivatives of C6706 str1, a spontaneous Smr mutant.
VOL. 64, 1996 MSHA GENE LOCUS 461
secretion locus and ORF1 of the mshA structural gene locus (Fig. 1A). The
MSH6 primer sequence is 59-AAAAGGATCCTTGCGGACAAATGATGCT-
39. The MSH7 primer sequence is 59-AAAAGGATCCATGCCGCGACAAAC
AC-39. The 1.3-kb PCR product was gel purified (GeneClean; Bio 101, Inc.,
Vista, Calif.) and used as a template for automated DNA sequencing with the
PRISM Ready Reaction Dye-Deoxy Terminator Cycle Sequencing Kit (Applied
Biosystems, Foster City, Calif.) primed with the flanking oligonucleotide PCR
primers described above. The resulting sequence was utilized to generate two
additional sets of internal oligonucleotide PCR primers to complete both strands
of the entire 1.3-kb intervening region. All sequence analysis was performed with
a model 373A automated DNA sequencer (Applied Biosystems).
Nucleotide sequence accession number. The DNA sequence generated has
been entered in the GenBank database under the accession number U35009.
RESULTS
Isolation and characterization of MSHA mutants. The
MSHA-negative mutant DS577 was identified by screening a
collection of C6706 isolates carrying random TnphoA inser-
tions by a hemagglutination assay. The hemagglutination titer
for the DS577 mutant was repeatedly 100-fold less than that
of the wild-type strain. (Hemagglutination titers for strains
C6706, DS577, JM34, JM2, and JM4 were 128, ,1, 2, 8, and 8,
respectively [results are means of three separate assays].) Se-
quence analysis demonstrated that the DS577 transposon in-
sertion lies within ORF4 of a genetic locus previously proposed
to encode products involved in the secretion of the MSHA
pilus (10), which will be referred to as the MSHA secretory
locus (Fig. 1). The sequence results also revealed that the phoA
gene of the insertion was out of frame with ORF4, accounting
for the extremely low level (4 U) of alkaline phosphatase
activity produced by this strain (data not shown). Genetic back-
cross of the cloned TnphoA insertion (see Materials and Meth-
ods) confirmed that the original MSHA-negative phenotype
was due to the transposon insertion and not a secondary mu-
tation. The backcross mutant JM34 displayed a 50- to 60-fold
decrease in its hemagglutination titer (see data above). Since
the TnphoA insertion lies towards the 39 end of ORF4, we were
interested in investigating the ORF5 contribution to this phe-
notype. We therefore performed targeted gene disruption at
ORF4 or ORF5 with the suicide vector pGP704 as described in
Materials and Methods (17). The resulting mutants, JM2 and
JM4, also exhibited a marked decrease in their ability to hem-
agglutinate, although at a consistently higher level than that
observed in the original DS577 TnphoA mutant or the back-
cross mutant JM34 (see above). Thus, disruption at either
ORF4 or ORF5 of the secretory locus resulted in a MSHA-
negative phenotype. These data are consistent with the find-
ings of Hase et al. in which null alleles of several other ORFs
within the proposed secretory locus also abolished mannose-
sensitive hemagglutination (10).
Construction of a chromosomal mshA-phoA gene fusion. To
determine the level at which the ORF4 gene product affects
the MSHA phenotype, we constructed a mshA-phoA gene fu-
sion in the V. cholerae C6706 chromosome and performed
targeted gene disruption at ORF4 by the suicide vector strat-
egy described above. While wild-type C6706 showed little en-
dogenous alkaline phosphatase activity (33 6 19 U [mean 6
standard deviation]), the mshA-phoA fusion strain JM53 pro-
duced a high level of alkaline phosphatase specific activity
(1,2946 24 U). JM73, themshA-phoA gene fusion carrying the
pGP704 vector insertion at ORF4, showed only a slightly lower
alkaline phosphatase activity (985 6 50 U) compared with that
of the mshA-phoA gene fusion alone. This reduction in specific
activity is not consistent with ORF4 playing a major regulatory
role in mshA expression. The high activity elaborated by the
MshA-alkaline phosphatase hybrid molecule in both strains
suggests efficient localization of at least the alkaline phos-
phatase portion of the hybrid molecule across the inner mem-
brane even in the absence of the ORF4 product. Thus, the
phenotype of the ORF4 disruption is consistent with a role for
this gene product in the later stages of pilus biogenesis, sub-
sequent to initial secretion across the inner membrane.
Southern blot analysis. To verify the construction of the V.
cholerae mutants in this study, we performed Southern blot
analysis. Genomic DNA from mutant strains was subjected to
restriction endonuclease digestion with SmaI. The wild-type
C6706 chromosome carries a SmaI site at the 39 end of ORF4
(Fig. 1A). Genetic alterations at this site can be detected easily
with probe A (Fig. 1A), which spans ORF4 and the 59 end of
ORF5. Hybridization of this probe to SmaI-digested C6706
genomic DNA revealed the presence of two bands, a 20-kb
band and a 16-kb band (bands 1 and 2, respectively) (Fig. 2A,
lane 1). Hybridization of probe A to SmaI-digested DS577
genomic DNA detected an increase in the size of band 2
corresponding to the insertion of TnphoA at ORF4 based on
the following rationale. Sequence analysis demonstrated that
FIG. 1. Schematic representation of the MSHA secretory and structural gene
loci. Open boxes indicate the locations and relative sizes of the ORFs. (A)
Probes A and B utilized in Southern blot analysis span the stippled regions as
indicated. A unique SmaI site is located within ORF4 of the secretory locus. The
1.3-kb intervening region is flanked by PCR primers MSH6 and MSH7, which
were utilized to amplify this region for automated sequence analysis. (B) The
DS577 TnphoA insertion is located within ORF4 of the secretory locus. A SmaI
site is located 3 kb upstream from the end of the TnphoA insert. (C) Reporter
construct mshA-phoA carries an additional SmaI site at the mshA-phoA junction
and a unique NotI site near the end of the phoA insertion.
FIG. 2. Southern blot of SmaI genomic digests. (A) Hybridization with
digoxigenin-labeled probe A. Lanes: 1, C6706; 2, DS577; 3, JM34; 4, JM2; 5,
JM4; 6, JM53; 7, JM73. Band 1 is ;20 kb corresponding to the genetic fragment
containing ORF4 of the secretory locus. Band 2 is ;16 kb corresponding to the
genetic fragment containing ORF5 of the secretory locus. Band 3 is ;4 kb
corresponding to the duplicated ORF4 sequences plus the inserted pGP704
vector. DNA size standards (lHindIII; Gibco BRL, Bethesda, Md.) are indi-
cated. (B) Hybridization with probe B of same blot as that shown in panel A.
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the TnphoA insertion in DS577 lies just 39 of the SmaI site at
ORF4 (Fig. 1B). Insertion of TnphoA at ORF4 would there-
fore result in an increase in size of the band (band 2) associ-
ated with ORF5. Because TnphoA carries a SmaI site ;3.2 kb
from its 39 terminus, we would expect to see band 2 of DS577
increase in size by ;3.2 kb. This was observed for both the
DS577 TnphoA mutant and the backcross mutant JM34 (Fig.
2A, lanes 2 and 3). These data demonstrate that ORF5 resides
on band 2 of the Southern blots hybridized with probe A.
The targeted gene disruptions at ORF4 and ORF5 were also
confirmed by Southern blot analysis with probe A. Insertion of
the pGP704 suicide vector into the V. cholerae chromosome at
ORF4 results in the duplication of the internal targeted se-
quences of ORF4, including the SmaI site, as depicted in Fig.
3A. Southern blot analysis of genomic DNA isolated from this
mutant, JM2, results in the production of three bands (Fig. 2A,
lane 4). Band 1 and band 2 remain unchanged. However,
insertion of pGP704 and the duplicated SmaI site results in an
additional hybridizing band (band 3) (Fig. 2A, lane 4) corre-
sponding to the pGP704 vector plus the duplicated ORF4
sequences. This finding is consistent with ORF4 residing on
band 1 of Southern blots hybridized with probe A. Genetic
disruption at ORF5 also results in the duplication of the tar-
geted ORF5 sequences (Fig. 3B). In the case of the JM4
mutant, disruption of ORF5 results in a 4-kb increase in the
size of band 2 which corresponds to insertion of the pGP704
vector plus duplicated ORF5 sequences (Fig. 2A, lane 5). In
addition to confirming the construction of these mutants, these
results demonstrate that band 1 lies 59 of the SmaI site in
ORF4, while band 2 lies 39 of this site in Southern blots hy-
bridized with probe A.
The mshA-phoA chromosomal insertion was confirmed by
use of probe B (Fig. 1A). Insertion of phoA at the mshA
structural gene results in the introduction of a second SmaI site
(Fig. 1C). We therefore expected hybridization of probe B to
SmaI-digested genomic DNA from the mshA-phoA fusion
JM53 to result in the production of two bands. Southern blot
analysis revealed a single band of 8 kb. We speculated that this
8-kb band was actually a doublet that could be resolved by
performing a double digest with SmaI and NotI (Fig. 1C). A
double digest with SmaI and NotI would release the 2.6-kb
phoA fragment, resulting in a decrease in size of one of the
8-kb bands and the appearance of a 5.4-kb band. The Southern
blot of SmaI- and NotI-digested genomic DNA from JM53
hybridized with probe B confirmed this prediction (Fig. 4A,
lane 4).
Linkage analysis. Confirmation of the ORF4 disruption in
the mshA-phoA genetic background suggested that the secre-
tory locus was physically linked to the mshA structural subunit
gene locus. This was apparent from the following results.
When SmaI-digested genomic DNA from the mshA-phoA
gene fusion JM53 was hybridized with probe A, band 2 was
reduced in size by 8 kb (Fig. 2A, lane 6). Furthermore, JM73,
the ORF4 disruption in the mshA-phoA genetic background,
showed a similar banding pattern, with the addition of band 3
corresponding to the pGP704 vector and duplicated ORF4
sequences (Fig. 2A, lane 7). Since ORF5 lies within band 2 in
SmaI genomic digests (see above) and insertion of phoA at the
mshA structural gene results in the addition of a SmaI site (Fig.
1C), an alteration in the hybridization pattern of SmaI-di-
gested genomic DNA from themshA-phoA fusion JM53 would
occur if the mshA gene locus was physically linked to the
secretory locus. This hypothesis was confirmed by analysis of
the SmaI genomic digests with probe B which hybridize to
mshA sequences (Fig. 1A). Southern blot analysis with probe B
of a SmaI genomic digest of C6706 revealed the presence of
the 16-kb band corresponding to band 2 in the Southern blot
with probe A (Fig. 2B, lane 1). The hybridization pattern of
probe B consistently followed the pattern of band 2 observed
for probe A in all the mutant backgrounds, confirming that the
mshA structural gene is physically linked to the secretory locus.
Orientation of the MSHA secretory locus with respect to the
mshA structural gene. To determine in what orientation the
secretory locus lies with respect to the mshA structural gene
locus, we compared the hybridization patterns from SmaI
genomic digests and SmaI-NotI double digests of the mshA-
phoA fusion JM53 with probe A (Fig. 4B). If the structural
gene locus was arranged in an orientation opposite to that of
the secretory gene locus, we would have expected band 2 to be
reduced in size as a result of the excision of phoA sequences in
a SmaI-NotI double digest (Fig. 1C). If, on the other hand,
both loci were arranged in the same orientation, we would
expect there to be no difference in the hybridization patterns
observed for the SmaI versus the SmaI-NotI digests. Indeed,
the banding pattern observed for the double digest hybridized
with probe A was the same as that observed for the SmaI digest
alone (Fig. 4B, lanes 2 and 4). This result establishes the
directionality of the mshA secretory locus with regard to the
mshA structural gene locus, i.e., the mshA secretory locus lies
upstream of the mshA structural gene locus and the genes are
all oriented in the same direction (Fig. 1A).
Intervening sequence analysis. PCR amplification of genom-
ic DNA from C6706 with the primers MSH6 and MSH7 re-
sulted in the production of a 1.3-kb product, consistent with
the predicted distance between these regions by Southern anal-
yses (data not shown). This product was utilized as template
for sequencing with the MSH6 and MSH7 primers. Additional
internal primers were generated as the sequence was extended
FIG. 3. Schematic representation of ORF4 (JM2) and ORF5 (JM4) genetic
disruptions. (A) Insertion of pGP704 carrying an internal ORF4 fragment (❙)
into the V. cholerae chromosome results in the production of two incomplete
copies of the ORF4 gene and the duplication of the SmaI site. (B) Insertion of
pGP704 carrying an internal ORF5 fragment (❙) into the V. cholerae chromosome
results in the production of two incomplete copies of the ORF5 gene.
FIG. 4. Southern blots of the wild-type C6706 (lanes 1 and 3) and mshA-
phoA fusion JM53 (lanes 2 and 4) strains. (A) Confirmation of mshA-phoA
construct2hybridzation with probe B. (B) Orientation of the mshA structural
locus2hybridization with probe A. Lanes: 1 and 2, SmaI genomic digests; 3 and
4, SmaI-NotI double digests. As described in the text, band 2 is detected with
either probe as a single band migrating at 16 kb in the C6706 lanes or at 8 kb (as
a single band detected with probe A or part of a doublet as detected with probe
B) in the JM53 lanes. DNA size standards (lHindIII; Gibco BRL) are indicated.
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to allow complete sequence analysis of both strands. Exami-
nation of the intervening region between the MSHA secretory
and structural gene loci identified an ORF which we have
termed mshG (Fig. 5). This gene is contiguous with the partial
ORF1 sequence of the MshA structural gene locus reported by
Jonson et al. (13). The mshG gene is 1,200 nucleotides in
length and encodes a protein with a predicted molecular mass
of 44,829 Da and an isoelectric point of 8.1. A database search
of the MshG amino acid sequence by use of the BLAST pro-
gram (2) revealed significant homology to the sequence of the
pilus assembly gene of Neisseria gonorrhoeae, pilG, an integral
cytoplasmic membrane protein (29). Topological analysis uti-
lizing the TopPred II software for membrane protein structure
predicts four membrane-spanning domains (5). In addition to
the identification ofmshG, we have completed the sequence of
the mshE gene discovered by Hase et al. (10), extending this
ORF by 120 nucleotides. The predicted protein product from
this completed sequence exhibits identical homologies as re-
ported previously; i.e., MshE is a putative nucleotide-binding
protein with homology to PulE of the pullulanase secretory
system (10).
DISCUSSION
We describe a V. cholerae El Tor-derived TnphoA mutant,
DS577, that is defective in its ability to hemagglutinate. The
DS577 TnphoA insertion maps to the fourth ORF of a poten-
tial MSHA secretory locus described by Hase et al. (10). In the
Hase study, Tn5 mutagenesis of ORF2, -3, -5, -6, -7, or -8
resulted in a MSHA-negative phenotype in each case. Our
studies of DS577 and the ORF4 mutant derivatives JM2 and
JM73 extend these findings. First, they further demonstrate the
necessity of this locus in maintaining a functional MSHA pilus.
Second, genetic disruption of ORF4 in the mshA-phoA re-
porter strain JM73 has no effect on alkaline phosphatase levels,
thus providing experimental evidence to suggest that this locus
is involved in later events of pilus expression, including assem-
bly and secretion at the bacterial cell surface.
We have established that the mshA structural gene of the
MSHA is physically linked to this secretory locus. Southern
blot analysis with two probes of different specificities demon-
strates that the MSHA structural gene locus and the secretory
gene locus are separated by a 1.3-kb intervening region. Se-
quence analysis of this region revealed the presence of an ORF
that is contiguous with the partial ORF1 sequence reported by
Jonson et al. (13). In keeping with the previously established
nomenclature, we have designated this ORF mshG and have
identified the other unnamed ORFs accordingly (Fig. 5). Fur-
thermore, we have changed the name of the secretory locus
ORF5 from mshD to mshL to eliminate redundancy with the
historically designated mshD of the structural locus.
The deduced MshG polypeptide has homology to several
bacterial proteins essential for type IV pilus assembly and
export, including PilG of N. gonorrhoeae (29) and PilC of
Pseudomonas aeruginosa (18). While the exact role of these
proteins in pilus assembly remains unclear, their predicted
location within the cytoplasmic membrane and the proximity of
their genes to those encoding either the structural subunit (P.
aeruginosa) or the prepilin leader peptidase (N. gonorrhoeae)
suggest a role in pilus assembly (18, 29). Unlike mshG of V.
cholerae, the pilG gene of N. gonorrhoeae is located upstream
of the gene encoding the prepilin peptidase PilD and is distal
to the pilin subunit gene pilE (29). Recent investigations have
demonstrated that type IV fimbrial biogenesis and function in
the opportunistic pathogen P. aeruginosa are dependent upon
a large number of genes which are located in three disparate
regions of the bacterial chromosome and show homology to a
network of proteins involved in the terminal stages of extra-
cellular protein secretion (1, 15). Like V. cholerae mshA, the P.
aeruginosa pilA structural subunit gene resides within a cluster
of genes that encode proteins with consensus prepilin sequenc-
es; however, pilA is transcribed in the direction opposite to that
of its ancillary genes (18). This transcriptional arrangement is
different from what we describe formshA. Our findings suggest
that the genes responsible for the secretion and assembly of the
MSHA pilus are all transcribed in the same orientation.
We propose that the MSHA structural and secretory loci
together constitute a biogenesis operon which is necessary for
the production, assembly, and secretion of functional MSHA
pili. While no true promoters have been identified in this
region, the organization of the 14 adjacent genes required for
the production of the MSHA pilus suggests that expression of
this locus could be driven by a single upstream promoter. The
decreased hemagglutination titers of DS577 and JM34 com-
pared with those observed for JM2 and JM4 are consistent
with TnphoA having a more-pronounced polar effect on down-
stream MSHA genes than that exhibited by the pGP704 inser-
tion. This type of organization where the secretory-assembly
components reside upstream of the pilin structural subunit
gene has been reported for several E. coli fimbrial biogenesis
operons (3, 20) but has never been observed for type IV pili.
Further investigation of the putative MSHA biogenesis operon
is necessary to elucidate its function with regard to V. cholerae
El Tor pathogenesis.
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